Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Vaishnavi Muralikrishnan"'
Autor:
Vaishnavi Muralikrishnan, Fang Fang, Tyler C. Given, Ram Podicheti, Mikhail Chtcherbinine, Tara X. Metcalfe, Shruthi Sriramkumar, Heather M. O’Hagan, Thomas D. Hurley, Kenneth P. Nephew
Publikováno v:
Cancers; Volume 14; Issue 14; Pages: 3437
Ovarian cancer is a deadly disease attributed to late-stage detection as well as recurrence and the development of chemoresistance. Ovarian cancer stem cells (OCSCs) are hypothesized to be largely responsible for the emergence of chemoresistant tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4447dea889eb3723012c0b5f9cfa5df7
Autor:
Vaishnavi Muralikrishnan, Fang Fang, Tyler C. Given, Ram Podicheti, Douglas B. Rusch, Thomas D. Hurley, Kenneth P. Nephew
Publikováno v:
Cancer Research. 82:897-897
High grade serous ovarian cancer (HGSOC) is the leading cause of death from gynecologic malignancies. Ovarian cancer stem cells (OCSCs) are hypothesized to contribute to the emergence of chemoresistant tumors. Aldehyde dehydrogenase 1A1 (ALDH1A1) is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a39d12d2ffd7eea5a533207e3877f7f
https://doi.org/10.1158/1538-7445.am2022-897
https://doi.org/10.1158/1538-7445.am2022-897
Autor:
Riddhi Sood, Shruthi Sriramkumar, Vaishnavi Muralikrishnan, Sikai Xiao, Weini Wang, Christiane Hassel, Kenneth P. Nephew, Heather M. O’Hagan
High grade serous ovarian cancer (HGSOC) is the most common and aggressive type of ovarian cancer. Platinum resistance is a common occurrence in HGSOC and a main cause of tumor relapse resulting in high patient mortality rates. Recurrent OC is enrich
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a81616bebba938563220f64e0c37b75
https://doi.org/10.1101/2021.03.18.435878
https://doi.org/10.1101/2021.03.18.435878
Publikováno v:
Cancer Research. 81:3095-3095
Epithelial ovarian cancer (OC) is the deadliest amongst gynecologic cancers with the majority of deaths caused by cancer recurrence. A new paradigm explaining tumor relapse involves the persistence of cancer stem cells after chemotherapy. OC stem cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0deaa8d7f0c24a8f02995632ced03d55
https://doi.org/10.1158/1538-7445.am2021-3095
https://doi.org/10.1158/1538-7445.am2021-3095
Publikováno v:
Cancers
Cancers, Vol 12, Iss 961, p 961 (2020)
Cancers, Vol 12, Iss 961, p 961 (2020)
Gynecologic cancers cause over 600,000 deaths annually in women worldwide. The development of chemoresistance after initial rounds of chemotherapy contributes to tumor relapse and death due to gynecologic malignancies. In this regard, cancer stem cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce482e7fd510d09c5a370a2efbb72dda
https://doi.org/10.3390/cancers12040961
https://doi.org/10.3390/cancers12040961
Publikováno v:
Cancers. Feb2023, Vol. 15 Issue 3, p631. 112p.
Autor:
Office, IJMS Editorial1 (AUTHOR)
Publikováno v:
International Journal of Molecular Sciences. Feb2023, Vol. 24 Issue 3, p2105. 248p.
Autor:
Muralikrishnan, Vaishnavi1 (AUTHOR) vmuralik@iu.edu, Fang, Fang2 (AUTHOR) ffang@indiana.edu, Given, Tyler C.1 (AUTHOR) tygiven@iu.edu, Podicheti, Ram3 (AUTHOR) mnrusimh@indiana.edu, Chtcherbinine, Mikhail4 (AUTHOR) mchtcher@iu.edu, Metcalfe, Tara X.1 (AUTHOR) txmetcal@iu.edu, Sriramkumar, Shruthi1 (AUTHOR) ssriramkumar@wistar.org, O'Hagan, Heather M.1,2,5 (AUTHOR) hmohagan@indiana.edu, Hurley, Thomas D.4 (AUTHOR) thurley@iupui.edu, Nephew, Kenneth P.1,2,6 (AUTHOR) thurley@iupui.edu
Publikováno v:
Cancers. Jul2022, Vol. 14 Issue 14, pN.PAG-N.PAG. 18p.
Publikováno v:
Current Oncology. Feb2022, Vol. 29 Issue 2, p675-686. 12p.
Publikováno v:
Genes; Feb2023, Vol. 14 Issue 2, p238, 51p